262 related articles for article (PubMed ID: 29759671)
1. Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families.
Tadros R; Nannenberg EA; Lieve KV; Škorić-Milosavljević D; Lahrouchi N; Lekanne Deprez RH; Vendrik J; Reckman YJ; Postema PG; Amin AS; Bezzina CR; Wilde AAM; Tan HL
JACC Clin Electrophysiol; 2017 Dec; 3(12):1400-1408. PubMed ID: 29759671
[TBL] [Abstract][Full Text] [Related]
2. Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes.
Kumar S; Peters S; Thompson T; Morgan N; Maccicoca I; Trainer A; Zentner D; Kalman JM; Winship I; Vohra JK
Heart Rhythm; 2013 Nov; 10(11):1653-60. PubMed ID: 23973953
[TBL] [Abstract][Full Text] [Related]
3. Dual phenotypic transmission in Brugada syndrome.
Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
[TBL] [Abstract][Full Text] [Related]
4. Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study.
Hohmann S; Rudic B; Konrad T; Duncker D; König T; Tülümen E; Rostock T; Borggrefe M; Veltmann C
Europace; 2017 Oct; 19(10):1723-1729. PubMed ID: 27915266
[TBL] [Abstract][Full Text] [Related]
5. Sudden cardiac death in families with premature cardiovascular disease.
Bruikman C; de Ronde MWJ; Amin A; Levy S; Lof P; de Ruijter U; Hovingh K; Tan HL; Pinto-Sietsma SJ
Heart; 2020 Feb; 106(3):228-232. PubMed ID: 31422358
[TBL] [Abstract][Full Text] [Related]
6. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
[TBL] [Abstract][Full Text] [Related]
7. The Diagnostic Yield of Brugada Syndrome After Sudden Death With Normal Autopsy.
Papadakis M; Papatheodorou E; Mellor G; Raju H; Bastiaenen R; Wijeyeratne Y; Wasim S; Ensam B; Finocchiaro G; Gray B; Malhotra A; D'Silva A; Edwards N; Cole D; Attard V; Batchvarov VN; Tome-Esteban M; Homfray T; Sheppard MN; Sharma S; Behr ER
J Am Coll Cardiol; 2018 Mar; 71(11):1204-1214. PubMed ID: 29544603
[TBL] [Abstract][Full Text] [Related]
8. Value of the sodium-channel blocker challenge in Brugada syndrome.
Therasse D; Sacher F; Babuty D; Mabo P; Mansourati J; Kyndt F; Redon R; Schott JJ; Barc J; Probst V; Gourraud JB
Int J Cardiol; 2017 Oct; 245():178-180. PubMed ID: 28784436
[TBL] [Abstract][Full Text] [Related]
9. Novel
Monasky MM; Micaglio E; Ciconte G; Rivolta I; Borrelli V; Ghiroldi A; D'Imperio S; Binda A; Melgari D; Benedetti S; Mitrovic P; Anastasia L; Mecarocci V; Ćalović Ž; Casari G; Pappone C
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946750
[TBL] [Abstract][Full Text] [Related]
10. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations.
Hong K; Brugada J; Oliva A; Berruezo-Sanchez A; Potenza D; Pollevick GD; Guerchicoff A; Matsuo K; Burashnikov E; Dumaine R; Towbin JA; Nesterenko V; Brugada P; Antzelevitch C; Brugada R
Circulation; 2004 Nov; 110(19):3023-7. PubMed ID: 15520322
[TBL] [Abstract][Full Text] [Related]
11. A balanced translocation disrupting SCN5A in a family with Brugada syndrome and sudden cardiac death.
Yeates L; Ingles J; Gray B; Singarayar S; Sy RW; Semsarian C; Bagnall RD
Heart Rhythm; 2019 Feb; 16(2):231-238. PubMed ID: 30170230
[TBL] [Abstract][Full Text] [Related]
12. Ventricular arrhythmia during ajmaline challenge for the Brugada syndrome.
Dobbels B; De Cleen D; Ector J
Europace; 2016 Oct; 18(10):1501-1506. PubMed ID: 26941343
[TBL] [Abstract][Full Text] [Related]
13. Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER).
Somani R; Krahn AD; Healey JS; Chauhan VS; Birnie DH; Champagne J; Sanatani S; Angaran P; Gow RM; Chakrabarti S; Gerull B; Yee R; Skanes AC; Gula LJ; Leong-Sit P; Klein GJ; Gollob MH; Talajic M; Gardner M; Simpson CS
Heart Rhythm; 2014 Jun; 11(6):1047-54. PubMed ID: 24657429
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Abnormalities in First-Degree Relatives of Unexplained Cardiac Arrest Victims: A Report From the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry.
Steinberg C; Padfield GJ; Champagne J; Sanatani S; Angaran P; Andrade JG; Roberts JD; Healey JS; Chauhan VS; Birnie DH; Janzen M; Gerull B; Klein GJ; Leather R; Simpson CS; Seifer C; Talajic M; Gardner M; Krahn AD
Circ Arrhythm Electrophysiol; 2016 Sep; 9(9):. PubMed ID: 27635072
[TBL] [Abstract][Full Text] [Related]
15. Cardiac evaluation of pediatric relatives in sudden arrhythmic death syndrome: a 2-center experience.
Wong LC; Roses-Noguer F; Till JA; Behr ER
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):800-6. PubMed ID: 25194972
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia.
Hasdemir C; Payzin S; Kocabas U; Sahin H; Yildirim N; Alp A; Aydin M; Pfeiffer R; Burashnikov E; Wu Y; Antzelevitch C
Heart Rhythm; 2015 Jul; 12(7):1584-94. PubMed ID: 25998140
[TBL] [Abstract][Full Text] [Related]
17. Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial study.
Gandjbakhch E; Fressart V; Duthoit G; Marquié C; Deharo JC; Pousset F; Hebert JL; Simon F; Himbert C; Klug D; Charron P; Hidden-Lucet F
Int J Cardiol; 2014 Mar; 172(1):256-8. PubMed ID: 24476701
[No Abstract] [Full Text] [Related]
18. The Utility of Sodium Channel Provocation in Unexplained Cardiac Arrest Survivors and Electrocardiographic Predictors of Ventricular Fibrillation Recurrence.
Ensam B; Cheung CC; Almehmadi F; Gregers Winkel B; Scrocco C; Brennan P; Leong K; Muir A; Vanarva A; Tfelt-Hansen J; Roberts JD; Krahn AD; Behr ER
Circ Arrhythm Electrophysiol; 2022 Dec; 15(12):e011263. PubMed ID: 36441561
[TBL] [Abstract][Full Text] [Related]
19. SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers.
Amin AS; Reckman YJ; Arbelo E; Spanjaart AM; Postema PG; Tadros R; Tanck MW; Van den Berg MP; Wilde AAM; Tan HL
Int J Cardiol; 2018 Sep; 266():128-132. PubMed ID: 29709244
[TBL] [Abstract][Full Text] [Related]
20. Ajmaline Testing and the Brugada Syndrome.
Rizzo A; Borio G; Sieira J; Van Dooren S; Overeinder I; Bala G; Pappaert G; Maj R; Osório TG; Terasawa M; Galli A; Cecchini F; Miraglia V; Ströker E; La Meir M; Brugada P; Chierchia GB; de Asmundis C
Am J Cardiol; 2020 Nov; 135():91-98. PubMed ID: 32861732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
